Hurco Companies (NASDAQ:HURC – Get Rating) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Monday.

American Woodmark (NASDAQ:AMWD – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Monday.

Brokerages expect Copart, Inc. (NASDAQ:CPRT – Get Rating) to announce $1.08 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Copart’s earnings. The lowest EPS estimate is $1.06 and the highest is $1.10. Copart reported earnings per share of $1.03 in the same quarter last year, which suggests a positive year-over-year growth rate of 4.9%. The business is scheduled to announce its next quarterly earnings results on Monday, January 1st.

Prometheus Biosciences, Inc. (NASDAQ:RXDX – Get Rating) has received an average recommendation of “Buy” from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $52.57.

Shares of Nkarta, Inc. (NASDAQ:NKTX – Get Rating) have received an average recommendation of “Buy” from the nine research firms that are currently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $49.13.

Shares of UserTesting Inc (NYSE:USER – Get Rating) have received an average recommendation of “Buy” from the twelve analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $13.60.

UiPath Inc. (NASDAQ:PATH – Get Rating) gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $16.83, but opened at $18.75. UiPath shares last traded at $18.99, with a volume of 111,464 shares changing hands. The healthcare company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. The business had revenue of $245.07 million for the quarter, compared to analyst estimates of $225.37 million. UiPath had a negative return on equity of 21.20% and a negative net margin of 58.91%. The company’s revenue was up 31.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.81) earnings per share.

Equities researchers at Piper Sandler started coverage on shares of NeoGenomics (NASDAQ:NEO – Get Rating) in a research report issued on Thursday, The Fly reports. The firm set an “overweight” rating on the medical research company’s stock.

United Therapeutics Co. (NASDAQ:UTHR – Get Rating)’s stock price traded down 3.1% during mid-day trading on Thursday following insider selling activity. The company traded as low as $224.15 and last traded at $224.15. 401 shares were traded during trading, a decline of 100% from the average session volume of 571,206 shares. The stock had previously closed at $231.29.Specifically, CEO Martine A. Rothblatt sold 3,000 shares of the stock in a transaction dated Friday, May 27th. The shares were sold at an average price of $231.27, for a total value of $693,810.00. Following the sale, the chief executive officer now owns 130 shares of the company’s stock, valued at approximately $30,065.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Paul A. Mahon sold 6,000 shares of the business’s stock in a transaction dated Thursday, March 17th. The shares were sold at an average price of $182.42, for a total transaction of $1,094,520.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 47,000 shares of company stock valued at $9,390,830. 12.10% of the stock is currently owned by insiders.

MongoDB, Inc. (NASDAQ:MDB – Get Rating) shares gapped up before the market opened on Thursday following a stronger than expected earnings report. The stock had previously closed at $241.81, but opened at $262.89. MongoDB shares last traded at $271.98, with a volume of 20,853 shares trading hands. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of ($1.34) by $1.54. The company had revenue of $285.45 million during the quarter, compared to the consensus estimate of $267.10 million. MongoDB had a negative return on equity of 66.70% and a negative net margin of 35.12%. MongoDB’s quarterly revenue was up 57.1% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.98) earnings per share.